BaSES Trial: Basel Starch Evaluation in Sepsis

PHASE4CompletedINTERVENTIONAL
Enrollment

231

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

May 31, 2011

Conditions
SepsisSevere SepsisSeptic Shock
Interventions
DRUG

hydroxy-ethyl starch (MW 130; 0.4) vs. normal saline

hydroxy-ethyl starch together with ringer's lactate versus physiologic saline together with saline

Trial Locations (2)

4031

Surgical ICU, University Hospital Basel, Basel

CH-4031

Medical ICU, Univesity Hospital Basel, Basel

All Listed Sponsors
collaborator

Fresenius AG

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT00273728 - BaSES Trial: Basel Starch Evaluation in Sepsis | Biotech Hunter | Biotech Hunter